NovoCure Warns Of Potential $11 Million Tariff Hit If US Trade Pause Expires In 2025

NovoCure Ltd NVCR reported a first-quarter 2025 loss of 31 cents, down from the 36-cent loss reported a year ago, beating the consensus loss of 46 cents.Sales increased 12% year over year to $155 million, beating the consensus of$146.6 million.The U.S., Germany, France, and Japan contributed $93.2 million,$18.7 million, $17.9 million, and$8.7 million, respectively, while other active markets contributed $11.9 million.Revenue in Greater China from Novocure’s partnership with Zai Lab totaled$4.6 million.R ...